Hepatitis B Foundation
BOARD OFFICERS
Chairman
Joel Rosen, Esq.
President
Timothy M. Block, Ph.D.
Vice President
W. Thomas London, MD
Treasurer
R. Donald Leedy, MBA
Secretary
Janine Witte
BOARD OF DIRECTORS
Joan M. Block, RN, BSN
Co-Founder and Executive Director
Hepatitis B Foundation
Thomas Block
President and CEO
Naked Chocolate Café
Timothy M. Block, Ph.D.
Co-Founder, Hepatitis B Foundation
Professor and Director, Drexel Institute for Biotechnology and Virology Research of
Drexel University College of Medicine
Stanley Broadbent
Sr. Vice-President/Director of Sales
Glenmede Trust Co.
Alan Brownstein, MPH
Executive Director
National Alliance for Thrombosis and Thrombophilia
Sandra Budinsky
Consultant
Coaching Solutions
James Datin
Executive Vice President, Life Sciences Group
Safeguard Scientifics
Kimberly Jungkind, MPH, BSN, RN
Clinical Epidemiologist
Thomas Jefferson University Hospital
Dale Kindregan
Vice President, Endowments & Foundations
PineBridge Investments
R. Donald Leedy, MBA
Executive Director
Alliance of Dedicated Cancer Centers
W. Thomas London, MD
Senior Member, IRB Chair
Fox Chase Cancer Center
Joel Rosen, Esq.
Senior Partner
High Swartz Roberts & Seidel
Charles Sigety, Esq.
Retired Business Executive
Gurney P. Sloan, Jr., Esq.
Retired Rohrer Pharma Executive
Catherine Williams, MGA
Janine Witte
Co-Founder, Hepatitis B Foundation
President, Originetics
Robert Zivin, Ph.D.
Senior Director, Corporate Office of Science & Technology
Johnson & Johnson
MEDICAL AND SCIENTIFIC ADVISORS
Harvey Alter, MD, Chief, Infectious Disease Section, Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD
Timothy M. Block, Ph.D., Professor and Director, Drexel Institute for Biotechnology and Virology Research of Drexel University College of Medicine, Philadelphia, PA
Baruch Blumberg, MD, Ph.D., Nobel laureate and Senior Member, Fox Chase Cancer Center, Phila, PA; Distinguished Scholar, Hepatitis B Foundation
Nathaniel Brown, MD, Senior Vice President, Clinical Development, Presidio Pharmaceuticals, San Francisco, CA
Carol Brosgart, MD, Chief Medical Officer, Alios BioPharma, Inc.
Raymond Dwek, D.Phil., FRS, Professor, University of Oxford and Founder, Glycobiology Institute at Oxford University, Oxford, UK
Lawrence Friedman, MD, Chair, Dept. of Medicine, Newton-Wellesley Hospital
Robert Gish, MD, Medical Director, Liver Transplant Program, California Pacific Medical Center, San Francisco, CA
Hie-Won L. Hann, MD, Professor and Director, Liver Disease Prevention Center, Thomas Jefferson University Hospital, Philadelphia, PA
W. Thomas London, MD, Senior Member, IRB Chair, Fox Chase Cancer Center, Philadelphia, PA
William Mason, Ph.D., Senior Member, Fox Chase Cancer Center, Philadelphia, PA
Brian McMahon, MD, Scientific and Clinical Director, Liver Disease and Hepatitis Program, Alaska Native Medical Center, Fairbanks, AK
Kenneth Rothstein, MD, Chair, Division of Gastroenterology and Hepatology Drexel University College of Medicine, Philadelphia, PA
Raymond Schinazi, Ph.D., Professor, Pediatrics and Chemistry, and Director of the Laboratory of Biochemical Pharmacology, Emory University, Atlanta, GA; Founder of RFS Pharma
Bud Tennant, DVM, James Law Professor, College of Veterinary Medicine, Cornell University, Ithaca, NY
SENIOR MANAGEMENT
Joan Block, RN, BSN
Co-Founder and Executive Director
Nelson Carvalho, MBA
Chief Financial Officer
Margaret Farley, MBA
Director of Programs
Fern Sanford
Director of Development
Page last modified June 24, 2011
